Source: StreetInsider

Press Release: BDSI : BioDelivery Sciences Reports Positive First Quarter 2018 Financial Results and Provides Corporate Update

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) today reported financial results for the first quarter ended March 31, 2018 and provided an update on recent business highlights.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Based on data from BDSI's latest SEC filings

Annual Revenue

Based on data from BDSI's latest SEC filings

Employees

Herm Cukier's photo - CEO of BDSI

CEO

Herm Cukier

CEO Approval Rating

84/100

BioDelivery is a pharmaceutical company that primarily focuses on developing medicines for pain management and addiction... Read more